Radiation Oncology
The Department of Radiation Oncology actively collaborates in the multidisciplinary care of patients with cancer with the use of external beam radiation (e.g. electrons, IMRT, SBRT/SABR) and brachytherapy (e.g. HDR, eye-plaque, LDR) to treat tumors. As a team, we work with both surgeons and medical oncologists from all other disease sites including breast, CNS, pediatric, head and neck, thoracic and lung, sarcoma, genitourinary, gynecologic, gastrointestinal, lymphomatous, cutaneous malignancies, melanoma / Merkel cell, and ophthalmologic cancers as well as certain benign disorders (Dupuytren’s contracture, keloids).
Our team focuses not only on novel radiation treatment delivery but also on technology to improve cancer care, research for prognosis, improving clinical and quality of life outcomes, as well as synergy with other treatments such as chemotherapy and immunotherapy. Multiple faculty and staff serve on national research committees and have active clinical, physics/technological, and basic science research. We participate in collaborative national and international trials. Radiation oncology is a full member of NRG, actively participates in SWOG as well as NTCN, and we are a NCI designated cancer center with state-of-the-art technology, including a new radiation treatment facility opened in 2018.
Not only do we care about ensuring the best clinical outcomes and trying to achieve the highest cure rates, but we also care about the personal well-being of our patients and collaborate with supportive care, social work and other practitioners to provide a holistic approach to treatment. Part of delivering the best care possible is by offering innovative research programs and clinical trials.
Staff
Clinical Research Nursing
Clinical Research Coordination
Research Data Coordination
Regulatory Coordination
News
 Many Non-Hodgkin’s Lymphoma Patients Can Skip Radiation, Suggests Study Led by UArizona Researcher
Results from a SWOG Cancer Research Network study, led by Daniel Persky, MD, found many patients with the most common type of non-Hodgkin’s lymphoma can skip radiation treatment, reducing both costs and the time to heal from treatment. |
 UA Team Uncovers Promising Lead in Genetic Approach to Treating Glioblastoma
University of Arizona scientists hope they have made progress toward a next-generation drug that may slow tumor growth and boost radiation’s effectiveness in patients with the deadly brain cancer. |
 UA Cancer Center Researchers Advocate new Approach To Treat Rare Tissue Disorder
Overall implications for this new approach suggest that low energy X-rays or electron beams have a high therapeutic ratio in relieving the limiting symptoms of “Scleredema of Buschke” and in improving the quality of life of the patients afflicted by it. |
The only National Cancer Institute-designated Comprehensive Cancer Center headquartered in the state of Arizona.
Bringing promising new therapies from the laboratory to the bedside is a high priority. The clinician scientists of the University of Arizona Cancer Center are engaged in more than 200 clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.